Study immune side effects after cancer immunotherapy
Part of Cancer, Immune system & allergy clinical trials.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- If you have cancer, you must have been treated with an immune therapy for cancer
- Those immune therapies include medicines that target CTLA-4, PD-1, or PD-L1 (or combinations)
- You may qualify if you have an autoimmune or inflammatory condition that looks like immune therapy side effects
- Or you may qualify as a healthy volunteer with a non-inflammatory condition and no cancer history
- You must be able to understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood, stool, and tissue samples from people who have had side effects from immunotherapy (a type of cancer treatment that helps your immune system fight cancer). It aims to learn more about these side effects, so doctors can better manage them in the future.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This study looks at what happens to your immune system after you start a type of cancer treatment called a checkpoint inhibitor. The goal is to better understand side effects related to “autoimmunity” (when the immune system starts attacking the body) and improve care.
This study is a registry that collects information on immune-related side effects in cancer patients receiving immunotherapy. It helps doctors understand and manage these side effects better.
This study sets up a real-world patient database to follow people starting cancer immunotherapy and record immune-related side effects. You may help doctors better understand who gets these side effects and how they change over time.
This study looks at side effects from immune checkpoint inhibitors in people with solid tumors. It aims to understand why side effects happen and who might be at risk, so doctors can better manage them.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.